Chris Abell Explained
Christopher Abell [4] (11 November 1957[5] – 26 October 2020) was a British biological chemist who was a professor of biological chemistry at the Yusuf Hamied Department of Chemistry and Todd-Hamied Fellow of Christ's College, Cambridge.[6] On his 2016 election to the Royal Society, Abell's research was described as having "changed the face of drug discovery."
Education
Abell was educated at St John's College, Cambridge, gaining an Bachelor of Arts degree in Natural Sciences in 1979 followed by PhD[7] on the topic of polyketide biosynthesis for research supervised by James Staunton in 1982.[8]
Career and research
Abell held a research fellowship in the laboratory of David E. Cane at Brown University, Providence, USA, studying terpene biosynthesis (1982–83). In 1984, Abell joined the department of chemistry of the University of Cambridge, successively holding the positions of demonstrator, lecturer and reader in chemical biology, and becoming professor in biological chemistry in 2002. He held visiting professorships at the Australian National University in Canberra, University of Santiago de Compostela, University of Canterbury, Christchurch, and the Paul Sabatier University, Toulouse.[9] He was a fellow of Christ's College, Cambridge, from 1986;[10] and was the college's Todd-Hamied Fellow.[11] In 2013 he was appointed the first director of postdoctoral affairs at the University of Cambridge,[12] and in 2016 was appointed pro-vice-chancellor for research.
Abell published over 200 papers. His research interests include vitamin and amino acid biosynthesis as targets for the rational design of antimicrobials; fragment-based approaches to enzyme inhibition; bacterial and plant riboswitches; reactions in microdroplets;[13] and biological nanotechnology.[14] His former doctoral students include Shankar Balasubramanian.[1]
Commercial ventures
Abell was the co-founder of several companies. In 1999, he co-founded Astex Technology Ltd, which uses fragment-based drug discovery technology to discover cancer therapeutics. In 2001, he co-founded Akubio, which developed biosensors for detecting bacteria and viruses; it was acquired by Inverness Medical Innovations in 2008.[15] In 2010, he co-founded Sphere Fluidics to develop microdroplet technology.[16] In 2012 he co-founded Aqdot, a company developing a new microencapsulation technology.[17]
Personal life
In 1981, he married Katherine Abell, who worked with him at the department of chemistry in Cambridge; they had a son. He died suddenly on 26 October 2020.
Awards and honours
His awards include the Imperial Chemical Industries (ICI) Prize in Organic Chemistry in 1992, the Hickinbottom Award of the Royal Society of Chemistry,[18] and a Yamada Science Foundation Award. In 2008 he was the MIT Novartis Lecturer, and in 2011 was a BIC International Fellow at the University of Canterbury, Christchurch, New Zealand.[19] He was elected a Fellow of the Academy of Medical Sciences (FMedSci) in 2012[20] and a Fellow of the Royal Society (FRS) in 2016.[21]
Selected publications
- Ciulli. Alessio. Abell. Chris. Fragment-based approaches to enzyme inhibition. Current Opinion in Biotechnology. 18. 6. 2007. 489–496. 0958-1669. 10.1016/j.copbio.2007.09.003. 17959370. 4441723.
- Blundell. Tom L.. Jhoti. Harren. Abell. Chris. High-throughput crystallography for lead discovery in drug design. Nature Reviews Drug Discovery. 1. 1. 2002. 45–54. 1474-1784. 10.1038/nrd706. 12119609. 10.1.1.538.3976. 3145020.
- From Microdroplets to Microfluidics: Selective Emulsion Separation in Microfluidic Devices[13]
- Huebner. A.. Srisa-Art. M.. Holt. D.. Abell. C.. Hollfelder. F.. deMello. A. J.. Edel. J. B.. Quantitative detection of protein expression in single cells using droplet microfluidics. Chemical Communications. 12. 2007. 1218–20. 1359-7345. 10.1039/b618570c. 17356761.
- Kerbarh. Olivier. Ciulli. Alessio. Chirgadze. Dimitri Y.. Blundell. Tom L.. Abell. Chris. Nucleophile Selectivity of Chorismate-Utilizing Enzymes. ChemBioChem. 8. 6. 2007. 622–624. 1439-4227. 10.1002/cbic.200700019. 17335098. 37100903.
- Howard. Nigel. Abell. Chris. Blakemore. Wendy. Chessari. Gianni. Congreve. Miles. Howard. Steven. Jhoti. Harren. Murray. Christopher W.. Seavers. Lisa C. A.. van Montfort. Rob L. M.. Application of Fragment Screening and Fragment Linking to the Discovery of Novel Thrombin Inhibitors†. Journal of Medicinal Chemistry. 49. 4. 2006. 1346–1355. 0022-2623. 10.1021/jm050850v. 16480269.
- Bruckbauer. Andreas. Zhou. Dejian. Kang. Dae-Joon. Korchev. Yuri E.. Abell. Chris. Klenerman. David. An Addressable Antibody Nanoarray Produced on a Nanostructured Surface. Journal of the American Chemical Society. 126. 21. 2004. 6508–6509. 0002-7863. 10.1021/ja0317426. 15161251.
- Bulloch. Esther M. M.. Jones. Michelle A.. Parker. Emily J.. Emily Parker. Osborne. Andrew P.. Stephens. Elaine. Davies. Gareth M.. Coggins. John R.. Abell. Chris. Identification of 4-Amino-4-deoxychorismate Synthase as the Molecular Target for the Antimicrobial Action of (6S)-6-Fluoroshikimate. Journal of the American Chemical Society. 126. 32. 2004. 9912–9913. 0002-7863. 10.1021/ja048312f. 15303852.
- Webb. Michael E.. Stephens. Elaine. Smith. Alison G.. Alison Gail Smith. Abell. Chris. Rapid screening by MALDI-TOF mass spectrometry to probe binding specificity at enzyme active sites. Chemical Communications. 19. 2003. 2416–7. 1359-7345. 10.1039/b308182f. 14587709.
- Cooper. Matthew A.. Dultsev. Fedor N.. Minson. Tony. Tony Minson. Ostanin. Victor P.. Abell. Chris. Klenerman. David. Nature Biotechnology. Direct and sensitive detection of a human virus by rupture event scanning. 19. 9. 2001. 833–837. 1087-0156. 10.1038/nbt0901-833. 11533641. 7307876.
- Albert. Armando. Dhanaraj. Venugopal. Genschel. Ulrich. Khan. Ghalib. Ramjee. Manoj K.. Pulido. Rosaline. Sibanda. B. Lynn. Delft. Frank von. Witty. Michael. Blundell. Tom L.. Tom Blundell. Smith. Alison G.. Alison Gail Smith. Abell. Chris. Crystal structure of aspartate decarboxylase at 2.2 Å resolution provides evidence for an ester in protein self–processing. Nature Structural Biology. 5. 4. 1998. 289–293. 1072-8368. 10.1038/nsb0498-289. 9546220. 7569959.
- Mahapatro. Mrinal. Gibson. Christopher. Abell. Chris. Rayment. Trevor. Chiral discrimination of basic and hydrophobic molecules by chemical force spectroscopy. Ultramicroscopy. 97. 1–4. 2003. 297–301. 0304-3991. 10.1016/S0304-3991(03)00055-X. 12801683.
Notes and References
- PhD . Shankar. Balasubramanian . Studies on the reaction mechanism of chorismate synthase . University of Cambridge . 1991 . 60112382. . lib.cam.ac.uk.
- PhD . Alessio. Ciulli . Biophysical studies of protein-ligand interactions . University of Cambridge . 2006 . . lib.cam.ac.uk.
- Web site: Christopher ABELL - Personal Appointments (free information from Companies House). beta.companieshouse.gov.uk.
- News: 57 . 27 October 2015 . Fellows (FRSC) . The Times .
- Abell, Prof Christopher. In Debrett's People of Today 2012 (accessed 15 January 2012) (subscription required)
- Web site: Scientific Advisory Board. https://web.archive.org/web/20130407084006/http://astx.com/about/scientific_advisory_board/. dead. 7 April 2013. 7 April 2013.
- PhD. University of Cambridge. Polyketide biosynthesis. Christopher. Abell. 1982. . lib.cam.ac.uk. 59312458.
- (accessed 15 January 2013)
- http://www.astex-therapeutics.com/about/sab.php Astex Therapeutics: Scientific Advisors and Clinical Consultants
- Web site: Christ's College Magazine 2019. Issuu. en. 2020-01-01. 18 May 2021. https://web.archive.org/web/20210518174529/https://issuu.com/christsalumni/docs/christsmag2019_sc_v5_web. dead.
- http://www.christs.cam.ac.uk/college-life/people/fellows/ Christ's College, University of Cambridge: The Fellows of Christ's College
- http://www.cam.ac.uk/for-staff/appointments/new-senior-post-to-support-post-doc-community University of Cambridge: new senior post to support post-doc community
- Theberge. Ashleigh B.. Courtois. Fabienne. Schaerli. Yolanda. Fischlechner. Martin. Abell. Chris. Hollfelder. Florian. Huck. Wilhelm T. S.. Microdroplets in Microfluidics: An Evolving Platform for Discoveries in Chemistry and Biology. Angewandte Chemie International Edition. 49. 34. 2010. 5846–5868. 1433-7851. 10.1002/anie.200906653. 20572214. 18609389 .
- http://www.ch.cam.ac.uk/staff/ca.html University of Cambridge: Department of Chemistry: Professor Chris Abell
- http://www.businessweekly.co.uk/biomedtech-/11002-recycled-cambridge-biosensor-technology-attracts-millions-in-investment Vargas L. Recycled Cambridge biosensor technology attracts millions in investment Business Weekly (27 August 2008)
- http://www.spherefluidics.com/news_2010.php Sphere Fluidics: 2010 News
- Web site: From farm to fame, Cambridge's 'cereal' life science entrepreneur Business Weekly Technology News Business news Cambridge and the East of England. Quested. Tony. www.businessweekly.co.uk. 2020-01-01.
- Web site: RSC Hickinbottom Award Previous Winners. www.rsc.org. 2020-01-01.
- http://www.bic.canterbury.ac.nz/International%20Fellows.shtml International Fellows
- http://www.acmedsci.ac.uk/p109.html The Academy of Medical Sciences: Fellows: Newly elected fellows
- Web site: Professor Christopher Abell Biography. Royal Society. 1 May 2016.